转氨酸心肌粉症:进展和模两可
Alexandrina Danilov1, Lorenzo D'Angelo2, Enklajd Marsela2
1Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
心脏粉症,特别是TTR粉症,越来越多地被认为是心力衰竭的原因. 诊断和向治疗的进步正在改善患者的治疗结果.
科学领域:
- 心脏病学
- 遗传学
- 药理学
背景情况:
- 心脏粉症是由蛋白质沉积异常引起的,主要是 transthyretin (TTR),导致透性心肌病 (CM).
- 越来越多的老年人和非洲裔美国人被诊断出ATTR-CM,这凸显了它的流行程度.
- 通过骨扫描进行非侵入性诊断已经取代了传统的组织活检.
研究的目的:
- 审查当前的诊断,治疗和查策略,以治疗心肌病 (ATTR-CM) 的跨氨化症.
- 讨论新兴的治疗方法以及人工智能在提高患者识别和诊断方面的作用.
主要方法:
- 对ATTR-CM诊断,治疗和查的当前文献的审查.
- 对已批准和正在研究的药物治疗和基因编辑技术的分析.
- 探索人工智能驱动的早期检测和诊断工具.
主要成果:
- 骨扫描可以准确,非侵入性地诊断ATTR粉样性.
- 有几种向治疗方法可用或正在开发中,包括TTR稳定剂,基因沉默剂和新药.
- 将人工智能整合到EMR中显示出有希望的风险患者和加快诊断.
结论:
- 由于越来越多的治疗选择,及时查和诊断ATTR-CM至关重要.
- 药物治疗,基因编辑和人工智能的进步正在改变ATTR-CM的管理.
- 综合先进诊断和人工智能的多学科方法对于最佳的患者护理至关重要.
更多相关视频
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
07:32Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
Published on: May 25, 2022
相关概念视频
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cardiomyopathy I: Introduction and Classification
